Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
There is controversy regarding the etiological role of gastroesophageal reflux and the benefit of antireflux medications in chronic rhinosinusitis. Gilani et al used data from the 2005 to 2010 National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey to examine national prescribing patterns for antireflux medication in patients with chronic rhinosinusitis. They found that these patients were significantly less likely to receive proton pump inhibitors, histamine receptor antagonists, antacids, or prokinetic agents than those without chronic rhinosinusitis. National practice patterns do not support antireflux therapy for chronic rhinosinusitis. Bock and Poetker provide an Invited Commentary.
Highlights. JAMA Otolaryngol Head Neck Surg. 2016;142(7):621. doi:10.1001/jamaoto.2015.1815